Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Endoscopic Tympanoplasty: Single Versus Double Flap Technique

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03922295
Recruitment Status : Completed
First Posted : April 19, 2019
Last Update Posted : April 19, 2019
Sponsor:
Information provided by (Responsible Party):
Noha A.Elkholy, Mansoura University

Brief Summary:
Aim of this study is to compare results of double and single flap techniques for tympanoplasty in chronic suppurative otitis media patients. Inclusion criteria include total or subtotal tympanic membrane perforations with limited anterior remnant and should be dry for at least 3 months. Patients with persistent discharge, cholesteatoma, ossicular affection or those with recurrent perforations after previous myringoplasty were excluded. Also, patients with uncontrolled diabetes, chronic liver and kidney diseases and immuno-compromised patients are not included in this study. Patients are divided into two groups, endoscopic double flap group and endoscopic single flap group. Healing and hearing outcomes were evaluated 3 months postoperative. Also, post-operative pain scores and complications were assessed.

Condition or disease Intervention/treatment Phase
Tympanic Membrane Perforation Procedure: Endoscopic tympanoplasty Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Endoscopic Tympanoplasty: Single Versus Double Flap Technique
Actual Study Start Date : August 24, 2017
Actual Primary Completion Date : October 20, 2018
Actual Study Completion Date : October 20, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endoscopy

Arm Intervention/treatment
Active Comparator: endoscopic double flap group Procedure: Endoscopic tympanoplasty

In the double flap group, graft is placed via elevation of both posterior and anterior flaps.

In the single flap group, graft is placed via elevation of posterior flap only


Active Comparator: endoscopic single flap group Procedure: Endoscopic tympanoplasty

In the double flap group, graft is placed via elevation of both posterior and anterior flaps.

In the single flap group, graft is placed via elevation of posterior flap only





Primary Outcome Measures :
  1. Healing or graft take rate [ Time Frame: 3 months after surgery ]
    closure of tympanic membrane perforation



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with chronic suppurative otitis media with total or subtotal tympanic membrane perforation with limited anterior remnant.
  • dry perforation for at least 3 months.

Exclusion Criteria:

  • Recurrent perforation after previous myringoplasty.
  • Ossicular disruption or fixation.
  • immune-compromised patients including uncontrolled diabetics, chronic liver and kidney diseases.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03922295


Locations
Layout table for location information
Egypt
ORL-HNS department,Mansoura University Hospital, Faculty of Medicine, Mansoura University
Mansoura, ElDakahlia, Egypt, 35516
Sponsors and Collaborators
Mansoura University
Investigators
Layout table for investigator information
Principal Investigator: Noha A Elkholy ORL-HNS department, Faculty of Medicine, Mansoura University
Study Director: Mohammed A Salem ORL-HNS department, Faculty of Medicine, Mansoura University
Study Chair: Abdelwahab M Rakha ORL-HNS department, Faculty of Medicine, Mansoura University
  Study Documents (Full-Text)

Documents provided by Noha A.Elkholy, Mansoura University:

Layout table for additonal information
Responsible Party: Noha A.Elkholy, ORL-HNS Resident, Mansoura University
ClinicalTrials.gov Identifier: NCT03922295     History of Changes
Other Study ID Numbers: 1ORL
First Posted: April 19, 2019    Key Record Dates
Last Update Posted: April 19, 2019
Last Verified: April 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Tympanic Membrane Perforation
Ear Diseases
Otorhinolaryngologic Diseases
Wounds and Injuries